Skip to content

Home
About
Products & Services
Quality & Compliance
News & Events
Contact

Home
About
Products & Services
Quality & Compliance
News & Events
Contact

Awaiting product image

Home / Formulation / Biological Drug Product / mAb Formulation / Dupilumab (Dupixent®) biosimilar

Biological Drug Product, Formulation, mAb Formulation

Dupilumab (Dupixent®) biosimilar

Categories: Biological Drug Product, Formulation, mAb Formulation

Description

• Phase 1 clinical trial to begin in 2024

Related products

Formulation
Recombinant Teriparatide for Injection
Biological Drug Product
Bevacizumab (BAT1706/AVZIVI®)
Biological Drug Product
Tocilizumab (BAT1806/TOFIDENCE®)
Formulation
Rocuronium Bromide Injection

Home
About
Products & Services
Quality & Compliance
News & Events
Contact

SHANDONG ZHIYE

Copyright © 2025-present zhiyesdcom. All Rights Reserved.

Added to cart

Your Cart Is Empty

0

Check out our shop to see what's available

Cart Total: Total$0.00

Your cart is empty. Shop now →

Scroll to Top